# Comparison of RA-IVL and RA-SHP in Calcified Coronary Lesions

Study · id `cardio:ct-nct07279987` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07279987](<https://clinicaltrials.gov/study/NCT07279987>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07279987

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 162 participants.

## Technical summary

Registry record NCT07279987. Randomized; single masking; primary purpose treatment. Start 2026-01-01 (anticipated); primary completion 2027-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 162 participants (planned count; ClinicalTrials.gov record NCT07279987, source copy `cardio:ctgov-nct07279987-2025-12-29`, retrieved 2026-10-26)
- Planned start: 2026-01-01 (anticipated) (ClinicalTrials.gov record NCT07279987, source copy `cardio:ctgov-nct07279987-2025-12-29`, retrieved 2026-10-26)
- Primary completion: 2027-12-31 (anticipated) (ClinicalTrials.gov record NCT07279987, source copy `cardio:ctgov-nct07279987-2025-12-29`, retrieved 2026-10-26)
- Completion: 2028-12-31 (anticipated) (ClinicalTrials.gov record NCT07279987, source copy `cardio:ctgov-nct07279987-2025-12-29`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT07279987, source copy `cardio:ctgov-nct07279987-2025-12-29`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07279987-2025-12-29`, retrieved 2026-10-26)

## The registry's words

- Brief title: Comparison of RA-IVL and RA-SHP in Calcified Coronary Lesions
- Acronym: CRUSH-CALC
- Condition: Vascular Calcification
- Intervention (Device): Super High-Pressure Non-Compliant Balloon
- Intervention (Device): Intravascular Lithotripsy System
- Lead sponsor: Lin Zhao
- Lead sponsor class: OTHER
- Collaborator: China-Japan Friendship Hospital
- Collaborator class: OTHER
- Collaborator: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as a collaborator: China-Japan Friendship Hospital (`cardio:org-china-japan-friendship-hospital`)
- Registry lists this organization as a collaborator: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine (`cardio:org-xinhua-hospital-shanghai-jiao-tong-university-school-of-9039af`)

## Provenance

Content hash: 17cdef96ca6ec65928bb1b22f0accf1f1550c5e2456e89c4ba362402bf1c0517
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
